Web Results

www.pacermonitor.com/public/case/25631065/Lewis_v_Bayer_HealthCare_Pharmaceuticals,_Inc_et_al

Sep 13, 2018 ... Lewis v. Bayer HealthCare Pharmaceuticals, Inc. et al (1:18-cv-08336), New York Southern District Court, Filed: 09/13/2018 - PacerMonitor ...

www.law360.com/cases/4d9b460c9f3b2561e4000003

Jan 30, 2015 ... BAYER HEALTHCARE PHARMACEUTICALS et al, case number ... Bayer Corp. has reached a deal Friday with current and former employees ...

caselaw.findlaw.com/us-8th-circuit/1687096.html

Case opinion for US 8th Circuit TOWNSEND v. ... Mike Townsend sued Bayer HealthCare Pharmaceuticals (Bayer) alleging Bayer wrongfully terminated ... See Diesel Mach., Inc. v. .... The district court denied all of Bayer's post-trial motions.

www.labaton.com/en/cases/Sandhaus-v-Bayer-Corp-et-al.cfm

Nov 23, 2017 ... Secured largest consumer recovery in Kansas from a pay-for-delay case. On November 23, 2015, the court granted final approval of a $4.5 ...

www.dailyreportingsuite.com/health/news/patient_s_facebook_posting_was_date_from_which_her_personal_injury_claims_accrued

Jan 30, 2017 ... Bayer Healthcare Pharmaceuticals, Inc., January 27, 2017, Koh, L.). ... California law applies a two-year statute of limitations for all personal ...

actrims.confex.com/actrims/2018/mediafile/Manuscript/Paper2519/ACTRIMS%202018_Alemtuzumab%20vs%20Cladribine%20MOA_Tornatore_v2.PDF

provided by Richard J Hogan, PhD, and Linda V Wychowski, PhD, ... studies were funded by Sanofi and Bayer HealthCare Pharmaceuticals. ... Genzyme Therapeutics, Inc. Cambridge, MA; 2017. 3. ... Cohen JA, et al. Lancet ... Pelletier D, et al.

www.ippractice.ca/litigation-statistics/intellectual-property-trials-jr-hearings-and-appeals

ATLANTIC LOTTERY CORPORATION ET AL, Patent Infringement, 2017-05-23 for 14 ... T-396-13, HOSPIRA HEALTHCARE CORPORATION v. ..... SYNTEX PHARMACEUTICALS INTERNATIONAL LTD. .... BAYER CROPSCIENCE INC. ...... Nadon, Pelletier) judgment, 2010 FCA 322 (Ltourneau, Nadon, Pelletier) judgment.

www.ncbi.nlm.nih.gov/pmc/articles/PMC4512519

Efficacy in patients who received peginterferon beta-1a for 2 years versus those ..... Douglas L. Arnold has received honoraria from Acorda Therapeutics, Bayer HealthCare, Biogen Idec Inc, ... Jean Pelletier has received consulting fees from Allergan, Bayer Schering Pharma, ... Calabresi PA, Kieseier BC, Arnold DL, et al.

www.ncbi.nlm.nih.gov/pmc/articles/PMC3320055

University of Texas Southwestern Medical Center, Dallas, TX ... the Advanced Imaging in Multiple Sclerosis (AIMS) Laboratory at UCSF (Dr. Daniel Pelletier, Director). ..... support from Acorda Therapeutics Inc., Bayer Schering Pharma, Biogen Idec, EMD Serono, Inc., Genentech, Inc., ... Vollmer T, Key L, Durkalski V, et al.